81 related articles for article (PubMed ID: 19423500)
1. Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography.
Kapse N; Goh V
Clin Colorectal Cancer; 2009 Mar; 8(2):77-87. PubMed ID: 19423500
[TBL] [Abstract][Full Text] [Related]
2. Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography.
Kapse N; Goh V
Clin Colorectal Cancer; 2009 Apr; 8(2):77-87. PubMed ID: 19739268
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
4. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of antiangiogenic agents.
Rehman S; Jayson GC
Oncologist; 2005 Feb; 10(2):92-103. PubMed ID: 15709211
[TBL] [Abstract][Full Text] [Related]
6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
7. Imaging of tumor physiology: impacts on clinical radiation oncology.
Astner ST; Shi K; Vaupel P; Molls M
Exp Oncol; 2010 Sep; 32(3):149-52. PubMed ID: 21403609
[TBL] [Abstract][Full Text] [Related]
8. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
9. [The role of advanced cardiac imaging methods in coronary artery disease].
Kiraç S
Anadolu Kardiyol Derg; 2008 Jul; 8 Suppl 1():1-4. PubMed ID: 18611832
[TBL] [Abstract][Full Text] [Related]
10. Trends in veterinary cancer imaging.
Wisner ER; Pollard RE
Vet Comp Oncol; 2004 Jun; 2(2):49-74. PubMed ID: 19379186
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
[TBL] [Abstract][Full Text] [Related]
12. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
[TBL] [Abstract][Full Text] [Related]
14. Imaging of oral cavity cancer.
Rumboldt Z; Day TA; Michel M
Oral Oncol; 2006 Oct; 42(9):854-65. PubMed ID: 16798060
[TBL] [Abstract][Full Text] [Related]
15. Whole-body diffusion-weighted magnetic resonance imaging: current evidence in oncology and potential role in colorectal cancer staging.
Lambregts DM; Maas M; Cappendijk VC; Prompers LM; Mottaghy FM; Beets GL; Beets-Tan RG
Eur J Cancer; 2011 Sep; 47(14):2107-16. PubMed ID: 21664810
[TBL] [Abstract][Full Text] [Related]
16. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
Choyke PL; Dwyer AJ; Knopp MV
J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
18. Lymph node staging.
Vogl T; Bisdas S
Top Magn Reson Imaging; 2007 Aug; 18(4):303-16. PubMed ID: 17893595
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
[TBL] [Abstract][Full Text] [Related]
20. Functional magnetic resonance imaging in cervical cancer: current evidence and future directions.
Kundu S; Chopra S; Verma A; Mahantshetty U; Engineer R; Shrivastava SK
J Cancer Res Ther; 2012; 8(1):11-8. PubMed ID: 22531506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
